Instil Bio, Inc. (TIL) Stock Forecast
TIL analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $7.00 average of analyst targets
- Upside to target
- +18.4% from the latest close
- Next earnings
- November 12, 2026
- 52-week range
- $5.91 – $20.19
TIL analyst ratings
1 analystsNumber of analysts at each rating.
TIL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TIL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.17 | −$0.17 | −$0.17 | −$2.01 | +91.5% | 1 |
| Current fiscal year (2026) | −$1.17 | −$1.17 | −$1.17 | −$10.70 | +89.1% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TIL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | — |
TIL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TIL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.33 | −$0.33 | −$0.17 | −$0.17 | −$0.17 | −48.5% | 1 up · 0 down |
| Current fiscal year (2026) | −$1.61 | −$1.61 | −$1.17 | −$1.17 | −$1.17 | −27.3% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TIL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TIL beat in 6 of 12.
What analysts expect from TIL
1 analysts cover Instil Bio; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.00, 18.4% above the latest close of $5.91. Analysts expect earnings of −$1.17 per share for 2026, +89.1% from a year earlier. Instil Bio beat the EPS estimate in 6 of the last 12 quarters.
Related: TIL income statement, TIL key metrics, TIL chart. See the TIL stock overview for the latest quote and news.
TIL forecast FAQ
What is Instil Bio's price target?
The average analyst price target for Instil Bio is $7.00, 18.4% above the latest close of $5.91.
Is Instil Bio a buy, hold or sell?
Of 1 analysts covering Instil Bio, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Instil Bio's EPS forecast?
Analysts forecast −$1.17 per share for 2026 (range −$1.17 to −$1.17).
When does Instil Bio report earnings?
Instil Bio is expected to report results for the quarter ending September 30, 2026 on November 12, 2026.
Does Instil Bio usually beat earnings estimates?
Instil Bio reported EPS at or above the analyst estimate in 6 of the last 12 quarters.